Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

June 1, 2022

Study Completion Date

July 31, 2022

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

human papilloma virus testing and genotyping in cervical cancer cases

an observational analytical prospective cross-sectional study was managed from July 2019 to July 2022 on 70 cervical cancer patients collected from gyne-oncology unit in Shatby obstetrics and gynecology university hospital of Alexandria medical school after taking a written consent and following approval by Alexandria medical school institutional ethics committee. All patients were subjected to full history taking as age, gravidity, parity, contraceptive history, medical disease, detailed marital history and smoking. Collection of the sample from all cases of the study for human papilloma virus testing and genotyping was done after diagnostic workup and before treatment of the study cases at any time in post-menopausal women and at mid cycles period in premenopausal women by cervical smear using PAP spatula and endocervical brush.

Trial Locations (1)

Unknown

Hossam Hassan El Sokkary, Alexandria

All Listed Sponsors
lead

Hossam Hassan Aly Hassan El Sokkary

OTHER

NCT05539274 - Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus | Biotech Hunter | Biotech Hunter